Prostate, Bladder Cancer Care Delays Common During Pandemic
Study characterized patient-reported delays in care of prostate cancer and bladder cancer at the national level.
All articles by Natasha Persaud
Prostate Cancer Grade Migration Documented
Grade group 1 prostate cancers declined as a proportion of all prostate cancers.
Efficacy, Safety of Triple Combo for Advanced Kidney Cancer Probed
Study provides preliminary data on triple therapy for advanced RCC while clinicians await definitive answers from the ongoing phase 3 COSMIC-313 trial.
COVID-19 mRNA Vaccine Efficacy Wanes Over Time in RCC Cases
Strategies such as booster doses appear warranted in this population.
Frontline Immunotherapy Appears Effective in mRCC With Poor Performance Status
Patients with poor performance status have been excluded from pivotal trials on metastatic renal cell carcinoma.
Obesity, Hyperglycemia Potentiate Family History’s Effect on Kidney Cancer Risk
Both genetic and lifestyle factors interact to increase the risks for renal cell carcinoma, investigators reported.
Cancer Risks, Mortality Vary With CKD Stage
The proportion of patients with chronic kidney disease who die from cancer may be underappreciated.
DXA Screening Rate Low Among Older Men Initiating ADT for Prostate Cancer
Study confirms the care gap in bone health management and fracture prevention among older men with prostate cancer receiving androgen deprivation therapy.
Cancer Is Associated With Increased Kidney Failure Risk
The risk for kidney failure requiring renal replacement therapy varies by cancer type, with multiple myeloma associated with the highest risk.
Prostate Cancer PLND Might Be Avoidable in Some With Negative PSMA PET/CT
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...